On August 30, 2021 Herantis Pharma Plc ("Herantis"), focusing on disease modifying therapies for debilitating neurodegenerative diseases, reported that Dr. Craig Cook, Chief Executive Officer, will hold 1×1 meetings and have a digital company presentation at the following investor conferences (Press release, Herantis Pharma, AUG 30, 2021, View Source,c3405763 [SID1234586989]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Pareto Securities’ 12th Annual Healthcare Conference 2021 – September 1-2, 2021

Virtual Presentation: September 1, 2021 at 11:30 – 12:00 EEST / 10:30 – 11:00 CEST

Redeye Investor Forum – September 2, 2021

Virtual Presentation at 17:20 – 17:40 EEST / 16:20 – 16:40 CEST

Swiss Biotech Day – September 7, 2021

1×1 meetings

MedInvest Central Nervous System Investor Conference – September 8-9, 2021

Virtual Presentation: September 9, 2021 at 17:00 – 17:30 EEST / 16:00 – 16:30 CEST

H.C. Wainwright 23rd Annual Global Investment Conference – September 13-15, 2021

Virtual Presentation: September 13, 2021 at 14:00 – 14:30 EEST / 13:00 – 13:30 CEST

All presentations will be available via a digital library, which is accessible to event participants only. Please contact the organizers at the Pareto Securities, Redeye, H.C. Wainwright, MedInvest, and Swiss Biotech if you wish to attend and/or schedule a meeting with Herantis.